Mortalin is a novel mediator of erythropoietin signaling

• Published in: European journal of haematology 2007-08, Vol.79 (2), p.114-125
• Main Authors: Ohtsuka, Rie, Abe, Yasunobu, Fujii, Tomomi, Yamamoto, Masahiro, Nishimura, Junji, Takayanagi, Ryoichi, Muta, Koichiro
• Format: Article
• Language: English
• Subjects: Down-Regulation; Electrophoresis, Gel, Two-Dimensional; erythrocytes; Erythroid Precursor Cells - drug effects; Erythroid Precursor Cells - metabolism; erythropoietin; Erythropoietin - pharmacology; Gene Expression Regulation; heat shock protein; hematopoiesis; HSP70 Heat-Shock Proteins - genetics; HSP70 Heat-Shock Proteins - metabolism; Humans; MAP Kinase Signaling System - drug effects; mortalin; Oligonucleotide Array Sequence Analysis; Phosphatidylinositol 3-Kinases - metabolism; Proto-Oncogene Proteins c-akt - metabolism; RNA, Messenger - genetics; RNA, Small Interfering - genetics; Up-Regulation
• ISSN: 0902-4441; 1600-0609
• DOI: 10.1111/j.1600-0609.2007.00870.x

Erythropoietin (EPO) stimulates erythroid growth by enhancing the proliferation, maturation and survival of late‐stage erythroid progenitor cells. However, the entire process of EPO stimulation remains undetermined. To further clarify the intracellular mechanisms by which EPO affects the growth of erythroid progenitor cells, we analyzed proteins obtained from purified human erythroid colony‐forming cells (ECFCs) cultured with or without EPO, and one of the proteins apparently related with EPO stimuli was identified as mortalin (mthsp70/PBP74/Grp75/mot‐2), which is a member of the heat shock protein 70 family of chaperones. The amount of mortalin mRNA in ECFCs increased in an EPO dose‐dependent manner, and ECFC growth was dependent on the amount of mortalin. Furthermore, expression of mortalin in ECFCs was suppressed by a phosphatidylinositol 3‐kinase inhibitor. Finally, we analyzed gene expression patterns in ECFCs cultured with or without EPO after treatment with mortalin small interfering RNA (siRNA) using a DNA microarray. When ECFCs treated with mortalin siRNA were cultured with EPO, the expression of several genes overlapped with the profile seen in control ECFCs cultured without EPO. Our data suggest that mortalin is involved in the mediation of EPO signaling and plays an important role in stimulating the growth of erythroid progenitor cells.